Table of Content

1 Human Hepatitis B Immunoglobulin Market Overview
1.1 Human Hepatitis B Immunoglobulin Product Scope
1.2 Human Hepatitis B Immunoglobulin Segment by Type
1.2.1 Global Human Hepatitis B Immunoglobulin Sales by Type (2016 & 2021 & 2027)
1.2.2 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
1.2.3 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
1.2.4 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
1.3 Human Hepatitis B Immunoglobulin Segment by Application
1.3.1 Global Human Hepatitis B Immunoglobulin Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hepatitis B Carrier
1.3.3 Hepatitis B Close Contacts
1.4 Human Hepatitis B Immunoglobulin Market Estimates and Forecasts (2016-2027)
1.4.1 Global Human Hepatitis B Immunoglobulin Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Human Hepatitis B Immunoglobulin Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Human Hepatitis B Immunoglobulin Price Trends (2016-2027)

2 Human Hepatitis B Immunoglobulin Estimates and Forecasts by Region
2.1 Global Human Hepatitis B Immunoglobulin Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Human Hepatitis B Immunoglobulin Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Human Hepatitis B Immunoglobulin Sales Market Share by Region (2016-2021)
2.2.2 Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region (2016-2021)
2.3 Global Human Hepatitis B Immunoglobulin Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Human Hepatitis B Immunoglobulin Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Human Hepatitis B Immunoglobulin Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Human Hepatitis B Immunoglobulin Estimates and Projections (2016-2027)
2.4.2 Europe Human Hepatitis B Immunoglobulin Estimates and Projections (2016-2027)
2.4.3 China Human Hepatitis B Immunoglobulin Estimates and Projections (2016-2027)
2.4.4 Japan Human Hepatitis B Immunoglobulin Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Human Hepatitis B Immunoglobulin Estimates and Projections (2016-2027)
2.4.6 India Human Hepatitis B Immunoglobulin Estimates and Projections (2016-2027)

3 Global Human Hepatitis B Immunoglobulin Competition Landscape by Players
3.1 Global Top Human Hepatitis B Immunoglobulin Players by Sales (2016-2021)
3.2 Global Top Human Hepatitis B Immunoglobulin Players by Revenue (2016-2021)
3.3 Global Human Hepatitis B Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Hepatitis B Immunoglobulin as of 2020)
3.4 Global Human Hepatitis B Immunoglobulin Average Price by Company (2016-2021)
3.5 Manufacturers Human Hepatitis B Immunoglobulin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Human Hepatitis B Immunoglobulin Market Size by Type
4.1 Global Human Hepatitis B Immunoglobulin Historic Market Review by Type (2016-2021)
4.1.1 Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2016-2021)
4.1.2 Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2016-2021)
4.1.3 Global Human Hepatitis B Immunoglobulin Price by Type (2016-2021)
4.2 Global Human Hepatitis B Immunoglobulin Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Human Hepatitis B Immunoglobulin Sales Forecast by Type (2022-2027)
4.2.2 Global Human Hepatitis B Immunoglobulin Revenue Forecast by Type (2022-2027)
4.2.3 Global Human Hepatitis B Immunoglobulin Price Forecast by Type (2022-2027)

5 Global Human Hepatitis B Immunoglobulin Market Size by Application
5.1 Global Human Hepatitis B Immunoglobulin Historic Market Review by Application (2016-2021)
5.1.1 Global Human Hepatitis B Immunoglobulin Sales Market Share by Application (2016-2021)
5.1.2 Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2016-2021)
5.1.3 Global Human Hepatitis B Immunoglobulin Price by Application (2016-2021)
5.2 Global Human Hepatitis B Immunoglobulin Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Human Hepatitis B Immunoglobulin Sales Forecast by Application (2022-2027)
5.2.2 Global Human Hepatitis B Immunoglobulin Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Hepatitis B Immunoglobulin Price Forecast by Application (2022-2027)

6 North America Human Hepatitis B Immunoglobulin Market Facts & Figures
6.1 North America Human Hepatitis B Immunoglobulin Sales by Company
6.1.1 North America Human Hepatitis B Immunoglobulin Sales by Company (2016-2021)
6.1.2 North America Human Hepatitis B Immunoglobulin Revenue by Company (2016-2021)
6.2 North America Human Hepatitis B Immunoglobulin Sales Breakdown by Type
6.2.1 North America Human Hepatitis B Immunoglobulin Sales Breakdown by Type (2016-2021)
6.2.2 North America Human Hepatitis B Immunoglobulin Sales Breakdown by Type (2022-2027)
6.3 North America Human Hepatitis B Immunoglobulin Sales Breakdown by Application
6.3.1 North America Human Hepatitis B Immunoglobulin Sales Breakdown by Application (2016-2021)
6.3.2 North America Human Hepatitis B Immunoglobulin Sales Breakdown by Application (2022-2027)

7 Europe Human Hepatitis B Immunoglobulin Market Facts & Figures
7.1 Europe Human Hepatitis B Immunoglobulin Sales by Company
7.1.1 Europe Human Hepatitis B Immunoglobulin Sales by Company (2016-2021)
7.1.2 Europe Human Hepatitis B Immunoglobulin Revenue by Company (2016-2021)
7.2 Europe Human Hepatitis B Immunoglobulin Sales Breakdown by Type
7.2.1 Europe Human Hepatitis B Immunoglobulin Sales Breakdown by Type (2016-2021)
7.2.2 Europe Human Hepatitis B Immunoglobulin Sales Breakdown by Type (2022-2027)
7.3 Europe Human Hepatitis B Immunoglobulin Sales Breakdown by Application
7.3.1 Europe 128 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 128 Sales Breakdown by Application (2022-2027)

8 China Human Hepatitis B Immunoglobulin Market Facts & Figures
8.1 China Human Hepatitis B Immunoglobulin Sales by Company
8.1.1 China Human Hepatitis B Immunoglobulin Sales by Company (2016-2021)
8.1.2 China Human Hepatitis B Immunoglobulin Revenue by Company (2016-2021)
8.2 China Human Hepatitis B Immunoglobulin Sales Breakdown by Type
8.2.1 China Human Hepatitis B Immunoglobulin Sales Breakdown by Type (2016-2021)
8.2.2 China Human Hepatitis B Immunoglobulin Sales Breakdown by Type (2022-2027)
8.3 China Human Hepatitis B Immunoglobulin Sales Breakdown by Application
8.3.1 China 157 Sales Breakdown by Application (2016-2021)
8.3.2 China 157 Sales Breakdown by Application (2022-2027)

9 Japan Human Hepatitis B Immunoglobulin Market Facts & Figures
9.1 Japan Human Hepatitis B Immunoglobulin Sales by Company
9.1.1 Japan Human Hepatitis B Immunoglobulin Sales by Company (2016-2021)
9.1.2 Japan Human Hepatitis B Immunoglobulin Revenue by Company (2016-2021)
9.2 Japan Human Hepatitis B Immunoglobulin Sales Breakdown by Type
9.2.1 Japan Human Hepatitis B Immunoglobulin Sales Breakdown by Type (2016-2021)
9.2.2 Japan Human Hepatitis B Immunoglobulin Sales Breakdown by Type (2022-2027)
9.3 Japan Human Hepatitis B Immunoglobulin Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Human Hepatitis B Immunoglobulin Market Facts & Figures
10.1 Southeast Asia Human Hepatitis B Immunoglobulin Sales by Company
10.1.1 Southeast Asia Human Hepatitis B Immunoglobulin Sales by Company (2016-2021)
10.1.2 Southeast Asia Human Hepatitis B Immunoglobulin Revenue by Company (2016-2021)
10.2 Southeast Asia Human Hepatitis B Immunoglobulin Sales Breakdown by Type
10.2.1 Southeast Asia Human Hepatitis B Immunoglobulin Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Human Hepatitis B Immunoglobulin Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Human Hepatitis B Immunoglobulin Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Human Hepatitis B Immunoglobulin Market Facts & Figures
11.1 India Human Hepatitis B Immunoglobulin Sales by Company
11.1.1 India Human Hepatitis B Immunoglobulin Sales by Company (2016-2021)
11.1.2 India Human Hepatitis B Immunoglobulin Revenue by Company (2016-2021)
11.2 India Human Hepatitis B Immunoglobulin Sales Breakdown by Type
11.2.1 India Human Hepatitis B Immunoglobulin Sales Breakdown by Type (2016-2021)
11.2.2 India Human Hepatitis B Immunoglobulin Sales Breakdown by Type (2022-2027)
11.3 India Human Hepatitis B Immunoglobulin Sales Breakdown by Application
11.3.1 India Human Hepatitis B Immunoglobulin Sales Breakdown by Application (2016-2021)
11.3.2 India Human Hepatitis B Immunoglobulin Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Human Hepatitis B Immunoglobulin Business
12.1 Baxter
12.1.1 Baxter Corporation Information
12.1.2 Baxter Business Overview
12.1.3 Baxter Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Baxter Human Hepatitis B Immunoglobulin Products Offered
12.1.5 Baxter Recent Development
12.2 CSL
12.2.1 CSL Corporation Information
12.2.2 CSL Business Overview
12.2.3 CSL Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 CSL Human Hepatitis B Immunoglobulin Products Offered
12.2.5 CSL Recent Development
12.3 Bayer
12.3.1 Bayer Corporation Information
12.3.2 Bayer Business Overview
12.3.3 Bayer Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bayer Human Hepatitis B Immunoglobulin Products Offered
12.3.5 Bayer Recent Development
12.4 Grifols
12.4.1 Grifols Corporation Information
12.4.2 Grifols Business Overview
12.4.3 Grifols Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Grifols Human Hepatitis B Immunoglobulin Products Offered
12.4.5 Grifols Recent Development
12.5 Octapharma
12.5.1 Octapharma Corporation Information
12.5.2 Octapharma Business Overview
12.5.3 Octapharma Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Octapharma Human Hepatitis B Immunoglobulin Products Offered
12.5.5 Octapharma Recent Development
12.6 Shanghai RAAS
12.6.1 Shanghai RAAS Corporation Information
12.6.2 Shanghai RAAS Business Overview
12.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Shanghai RAAS Human Hepatitis B Immunoglobulin Products Offered
12.6.5 Shanghai RAAS Recent Development
12.7 Hualan Biological
12.7.1 Hualan Biological Corporation Information
12.7.2 Hualan Biological Business Overview
12.7.3 Hualan Biological Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hualan Biological Human Hepatitis B Immunoglobulin Products Offered
12.7.5 Hualan Biological Recent Development
12.8 China Biologic
12.8.1 China Biologic Corporation Information
12.8.2 China Biologic Business Overview
12.8.3 China Biologic Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 China Biologic Human Hepatitis B Immunoglobulin Products Offered
12.8.5 China Biologic Recent Development
12.9 Tiantan Biologic
12.9.1 Tiantan Biologic Corporation Information
12.9.2 Tiantan Biologic Business Overview
12.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Tiantan Biologic Human Hepatitis B Immunoglobulin Products Offered
12.9.5 Tiantan Biologic Recent Development
12.10 Shuanglin Bio-pharmacy
12.10.1 Shuanglin Bio-pharmacy Corporation Information
12.10.2 Shuanglin Bio-pharmacy Business Overview
12.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Products Offered
12.10.5 Shuanglin Bio-pharmacy Recent Development
12.11 Sichuan Yuanda Shuyang
12.11.1 Sichuan Yuanda Shuyang Corporation Information
12.11.2 Sichuan Yuanda Shuyang Business Overview
12.11.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Products Offered
12.11.5 Sichuan Yuanda Shuyang Recent Development
12.12 Boya Bio-pharmaceutical
12.12.1 Boya Bio-pharmaceutical Corporation Information
12.12.2 Boya Bio-pharmaceutical Business Overview
12.12.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Products Offered
12.12.5 Boya Bio-pharmaceutical Recent Development
12.13 Shanghai Institute of Biological
12.13.1 Shanghai Institute of Biological Corporation Information
12.13.2 Shanghai Institute of Biological Business Overview
12.13.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Products Offered
12.13.5 Shanghai Institute of Biological Recent Development

13 Human Hepatitis B Immunoglobulin Manufacturing Cost Analysis
13.1 Human Hepatitis B Immunoglobulin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Hepatitis B Immunoglobulin
13.4 Human Hepatitis B Immunoglobulin Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Hepatitis B Immunoglobulin Distributors List
14.3 Human Hepatitis B Immunoglobulin Customers

15 Market Dynamics
15.1 Human Hepatitis B Immunoglobulin Market Trends
15.2 Human Hepatitis B Immunoglobulin Drivers
15.3 Human Hepatitis B Immunoglobulin Market Challenges
15.4 Human Hepatitis B Immunoglobulin Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Hepatitis B Immunoglobulin Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Human Hepatitis B Immunoglobulin Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Human Hepatitis B Immunoglobulin Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Human Hepatitis B Immunoglobulin Sales (K MT) by Region (2016-2021)
Table 5. Global Human Hepatitis B Immunoglobulin Sales Market Share by Region (2016-2021)
Table 6. Global Human Hepatitis B Immunoglobulin Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Human Hepatitis B Immunoglobulin Revenue Share by Region (2016-2021)
Table 8. Global Human Hepatitis B Immunoglobulin Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Human Hepatitis B Immunoglobulin Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Human Hepatitis B Immunoglobulin Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Human Hepatitis B Immunoglobulin Revenue Share Forecast by Region (2022-2027)
Table 12. Global Human Hepatitis B Immunoglobulin Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Human Hepatitis B Immunoglobulin Sales Share by Company (2016-2021)
Table 14. Global Human Hepatitis B Immunoglobulin Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Human Hepatitis B Immunoglobulin Revenue Share by Company (2016-2021)
Table 16. Global Human Hepatitis B Immunoglobulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Hepatitis B Immunoglobulin as of 2020)
Table 17. Global Human Hepatitis B Immunoglobulin Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Human Hepatitis B Immunoglobulin Manufacturing Sites and Area Served
Table 19. Manufacturers Human Hepatitis B Immunoglobulin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Human Hepatitis B Immunoglobulin Sales (K MT) by Type (2016-2021)
Table 22. Global Human Hepatitis B Immunoglobulin Sales Share by Type (2016-2021)
Table 23. Global Human Hepatitis B Immunoglobulin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Human Hepatitis B Immunoglobulin Price (USD/MT) by Type (2016-2021)
Table 25. Global Human Hepatitis B Immunoglobulin Sales Share by Type (2022-2027)
Table 26. Global Human Hepatitis B Immunoglobulin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Human Hepatitis B Immunoglobulin Revenue Share by Type (2022-2027)
Table 28. Global Human Hepatitis B Immunoglobulin Price (USD/MT) by Type (2022-2027)
Table 29. Global Human Hepatitis B Immunoglobulin Sales (K MT) by Application (2016-2021)
Table 30. Global Human Hepatitis B Immunoglobulin Sales Share by Application (2016-2021)
Table 31. Global Human Hepatitis B Immunoglobulin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Human Hepatitis B Immunoglobulin Price (USD/MT) by Application (2016-2021)
Table 33. Global Human Hepatitis B Immunoglobulin Sales (K MT) by Application (2022-2027)
Table 34. Global Human Hepatitis B Immunoglobulin Sales Share by Application (2022-2027)
Table 35. Global Human Hepatitis B Immunoglobulin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Human Hepatitis B Immunoglobulin Revenue Share by Application (2022-2027)
Table 37. Global Human Hepatitis B Immunoglobulin Price (USD/MT) by Application (2022-2027)
Table 38. North America Human Hepatitis B Immunoglobulin Sales (K MT) by Company (2016-2021)
Table 39. North America Human Hepatitis B Immunoglobulin Sales Market Share by Company (2016-2021)
Table 40. North America Human Hepatitis B Immunoglobulin Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Human Hepatitis B Immunoglobulin Revenue Market Share by Company (2016-2021)
Table 42. North America Human Hepatitis B Immunoglobulin Sales by Type (2016-2021) & (K MT)
Table 43. North America Human Hepatitis B Immunoglobulin Sales Market Share by Type (2016-2021)
Table 44. North America Human Hepatitis B Immunoglobulin Sales by Type (2022-2027) & (K MT)
Table 45. North America Human Hepatitis B Immunoglobulin Sales Market Share by Type (2022-2027)
Table 46. North America Human Hepatitis B Immunoglobulin Sales by Application (2016-2021) & (K MT)
Table 47. North America Human Hepatitis B Immunoglobulin Sales Market Share by Application (2016-2021)
Table 48. North America Human Hepatitis B Immunoglobulin Sales by Application (2022-2027) & (K MT)
Table 49. North America Human Hepatitis B Immunoglobulin Sales Market Share by Application (2022-2027)
Table 50. Europe Human Hepatitis B Immunoglobulin Sales (K MT) by Company (2016-2021)
Table 51. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Company (2016-2021)
Table 52. Europe Human Hepatitis B Immunoglobulin Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Human Hepatitis B Immunoglobulin Revenue Market Share by Company (2016-2021)
Table 54. Europe Human Hepatitis B Immunoglobulin Sales by Type (2016-2021) & (K MT)
Table 55. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Type (2016-2021)
Table 56. Europe Human Hepatitis B Immunoglobulin Sales by Type (2022-2027) & (K MT)
Table 57. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Type (2022-2027)
Table 58. Europe Human Hepatitis B Immunoglobulin Sales by Application (2016-2021) & (K MT)
Table 59. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Application (2016-2021)
Table 60. Europe Human Hepatitis B Immunoglobulin Sales by Application (2022-2027) & (K MT)
Table 61. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Application (2022-2027)
Table 62. China Human Hepatitis B Immunoglobulin Sales (K MT) by Company (2016-2021)
Table 63. China Human Hepatitis B Immunoglobulin Sales Market Share by Company (2016-2021)
Table 64. China Human Hepatitis B Immunoglobulin Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Human Hepatitis B Immunoglobulin Revenue Market Share by Company (2016-2021)
Table 66. China Human Hepatitis B Immunoglobulin Sales by Type (2016-2021) & (K MT)
Table 67. China Human Hepatitis B Immunoglobulin Sales Market Share by Type (2016-2021)
Table 68. China Human Hepatitis B Immunoglobulin Sales by Type (2022-2027) & (K MT)
Table 69. China Human Hepatitis B Immunoglobulin Sales Market Share by Type (2022-2027)
Table 70. China Human Hepatitis B Immunoglobulin Sales by Application (2016-2021) & (K MT)
Table 71. China Human Hepatitis B Immunoglobulin Sales Market Share by Application (2016-2021)
Table 72. China Human Hepatitis B Immunoglobulin Sales by Application (2022-2027) & (K MT)
Table 73. China Human Hepatitis B Immunoglobulin Sales Market Share by Application (2022-2027)
Table 74. Japan Human Hepatitis B Immunoglobulin Sales (K MT) by Company (2016-2021)
Table 75. Japan Human Hepatitis B Immunoglobulin Sales Market Share by Company (2016-2021)
Table 76. Japan Human Hepatitis B Immunoglobulin Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Human Hepatitis B Immunoglobulin Revenue Market Share by Company (2016-2021)
Table 78. Japan Human Hepatitis B Immunoglobulin Sales by Type (2016-2021) & (K MT)
Table 79. Japan Human Hepatitis B Immunoglobulin Sales Market Share by Type (2016-2021)
Table 80. Japan Human Hepatitis B Immunoglobulin Sales by Type (2022-2027) & (K MT)
Table 81. Japan Human Hepatitis B Immunoglobulin Sales Market Share by Type (2022-2027)
Table 82. Japan Human Hepatitis B Immunoglobulin Sales by Application (2016-2021) & (K MT)
Table 83. Japan Human Hepatitis B Immunoglobulin Sales Market Share by Application (2016-2021)
Table 84. Japan Human Hepatitis B Immunoglobulin Sales by Application (2022-2027) & (K MT)
Table 85. Japan Human Hepatitis B Immunoglobulin Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Human Hepatitis B Immunoglobulin Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Human Hepatitis B Immunoglobulin Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Human Hepatitis B Immunoglobulin Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Human Hepatitis B Immunoglobulin Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Human Hepatitis B Immunoglobulin Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Human Hepatitis B Immunoglobulin Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Human Hepatitis B Immunoglobulin Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Human Hepatitis B Immunoglobulin Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Human Hepatitis B Immunoglobulin Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Human Hepatitis B Immunoglobulin Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Human Hepatitis B Immunoglobulin Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Human Hepatitis B Immunoglobulin Sales Market Share by Application (2022-2027)
Table 98. India Human Hepatitis B Immunoglobulin Sales (K MT) by Company (2016-2021)
Table 99. India Human Hepatitis B Immunoglobulin Sales Market Share by Company (2016-2021)
Table 100. India Human Hepatitis B Immunoglobulin Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Human Hepatitis B Immunoglobulin Revenue Market Share by Company (2016-2021)
Table 102. India Human Hepatitis B Immunoglobulin Sales by Type (2016-2021) & (K MT)
Table 103. India Human Hepatitis B Immunoglobulin Sales Market Share by Type (2016-2021)
Table 104. India Human Hepatitis B Immunoglobulin Sales by Type (2022-2027) & (K MT)
Table 105. India Human Hepatitis B Immunoglobulin Sales Market Share by Type (2022-2027)
Table 106. India Human Hepatitis B Immunoglobulin Sales by Application (2016-2021) & (K MT)
Table 107. India Human Hepatitis B Immunoglobulin Sales Market Share by Application (2016-2021)
Table 108. India Human Hepatitis B Immunoglobulin Sales by Application (2022-2027) & (K MT)
Table 109. India Human Hepatitis B Immunoglobulin Sales Market Share by Application (2022-2027)
Table 110. Baxter Corporation Information
Table 111. Baxter Description and Business Overview
Table 112. Baxter Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Baxter Human Hepatitis B Immunoglobulin Product
Table 114. Baxter Recent Development
Table 115. CSL Corporation Information
Table 116. CSL Description and Business Overview
Table 117. CSL Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. CSL Human Hepatitis B Immunoglobulin Product
Table 119. CSL Recent Development
Table 120. Bayer Corporation Information
Table 121. Bayer Description and Business Overview
Table 122. Bayer Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Bayer Human Hepatitis B Immunoglobulin Product
Table 124. Bayer Recent Development
Table 125. Grifols Corporation Information
Table 126. Grifols Description and Business Overview
Table 127. Grifols Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Grifols Human Hepatitis B Immunoglobulin Product
Table 129. Grifols Recent Development
Table 130. Octapharma Corporation Information
Table 131. Octapharma Description and Business Overview
Table 132. Octapharma Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Octapharma Human Hepatitis B Immunoglobulin Product
Table 134. Octapharma Recent Development
Table 135. Shanghai RAAS Corporation Information
Table 136. Shanghai RAAS Description and Business Overview
Table 137. Shanghai RAAS Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Shanghai RAAS Human Hepatitis B Immunoglobulin Product
Table 139. Shanghai RAAS Recent Development
Table 140. Hualan Biological Corporation Information
Table 141. Hualan Biological Description and Business Overview
Table 142. Hualan Biological Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Hualan Biological Human Hepatitis B Immunoglobulin Product
Table 144. Hualan Biological Recent Development
Table 145. China Biologic Corporation Information
Table 146. China Biologic Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. China Biologic Description and Business Overview
Table 148. China Biologic Human Hepatitis B Immunoglobulin Product
Table 149. China Biologic Recent Development
Table 150. Tiantan Biologic Corporation Information
Table 151. Tiantan Biologic Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Tiantan Biologic Description and Business Overview
Table 153. Tiantan Biologic Human Hepatitis B Immunoglobulin Product
Table 154. Tiantan Biologic Recent Development
Table 155. Shuanglin Bio-pharmacy Corporation Information
Table 156. Shuanglin Bio-pharmacy Description and Business Overview
Table 157. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Product
Table 159. Shuanglin Bio-pharmacy Recent Development
Table 160. Sichuan Yuanda Shuyang Corporation Information
Table 161. Sichuan Yuanda Shuyang Description and Business Overview
Table 162. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Product
Table 164. Sichuan Yuanda Shuyang Recent Development
Table 165. Boya Bio-pharmaceutical Corporation Information
Table 166. Boya Bio-pharmaceutical Description and Business Overview
Table 167. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Product
Table 169. Boya Bio-pharmaceutical Recent Development
Table 170. Shanghai Institute of Biological Corporation Information
Table 171. Shanghai Institute of Biological Description and Business Overview
Table 172. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Product
Table 174. Shanghai Institute of Biological Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Human Hepatitis B Immunoglobulin Distributors List
Table 178. Human Hepatitis B Immunoglobulin Customers List
Table 179. Human Hepatitis B Immunoglobulin Market Trends
Table 180. Human Hepatitis B Immunoglobulin Market Drivers
Table 181. Human Hepatitis B Immunoglobulin Market Challenges
Table 182. Human Hepatitis B Immunoglobulin Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Hepatitis B Immunoglobulin Product Picture
Figure 2. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type in 2021 & 2027
Figure 3. 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Product Picture
Figure 4. 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Product Picture
Figure 5. 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Product Picture
Figure 6. Global Human Hepatitis B Immunoglobulin Sales Market Share by Application in 2021 & 2027
Figure 7. Hepatitis B Carrier Examples
Figure 8. Hepatitis B Close Contacts Examples
Figure 9. Global Human Hepatitis B Immunoglobulin Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Human Hepatitis B Immunoglobulin Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Human Hepatitis B Immunoglobulin Sales (K MT) Growth Rate (2016-2027)
Figure 12. Global Human Hepatitis B Immunoglobulin Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 13. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Human Hepatitis B Immunoglobulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Human Hepatitis B Immunoglobulin Sales (K MT) Growth Rate (2016-2027)
Figure 17. Europe Human Hepatitis B Immunoglobulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Human Hepatitis B Immunoglobulin Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Human Hepatitis B Immunoglobulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Human Hepatitis B Immunoglobulin Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Human Hepatitis B Immunoglobulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Human Hepatitis B Immunoglobulin Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Human Hepatitis B Immunoglobulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Human Hepatitis B Immunoglobulin Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Human Hepatitis B Immunoglobulin Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Human Hepatitis B Immunoglobulin Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Human Hepatitis B Immunoglobulin Players Market Share by Revenue in Human Hepatitis B Immunoglobulin: 2016 & 2020
Figure 28. Human Hepatitis B Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Human Hepatitis B Immunoglobulin Revenue Share by Type (2016-2021)
Figure 30. Global Human Hepatitis B Immunoglobulin Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Human Hepatitis B Immunoglobulin Revenue Share by Application (2016-2021)
Figure 32. Global Human Hepatitis B Immunoglobulin Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Human Hepatitis B Immunoglobulin Sales Market Share by Type in 2020
Figure 34. North America Human Hepatitis B Immunoglobulin Sales Market Share by Application in 2020
Figure 35. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Type in 2020
Figure 36. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Application in 2020
Figure 37. China Human Hepatitis B Immunoglobulin Sales Market Share by Type in 2020
Figure 38. China Human Hepatitis B Immunoglobulin Sales Market Share by Application in 2020
Figure 39. Japan Human Hepatitis B Immunoglobulin Sales Market Share by Type in 2020
Figure 40. Japan Human Hepatitis B Immunoglobulin Sales Market Share by Application in 2020
Figure 41. Southeast Asia Human Hepatitis B Immunoglobulin Sales Market Share by Type in 2020
Figure 42. Southeast Asia Human Hepatitis B Immunoglobulin Sales Market Share by Application in 2020
Figure 43. India Human Hepatitis B Immunoglobulin Sales Market Share by Type in 2020
Figure 44. India Human Hepatitis B Immunoglobulin Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Human Hepatitis B Immunoglobulin
Figure 47. Manufacturing Process Analysis of Human Hepatitis B Immunoglobulin
Figure 48. Human Hepatitis B Immunoglobulin Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed